DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR EC-NAPROSYN

« Back to Dashboard

All Clinical Trials for Ec-naprosyn

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00153660	Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients	Unknown status	Chinese University of Hong Kong	Phase 3	2005-06-01	The aim of this study is to compare a PPI (esomeprazole) plus a COX-2 inhibitor (celecoxib) with a PPI plus a nonselective NSAID (naproxen) in preventing recurrent ulcer bleeding in arthritis patients with a history of ulcer. The investigators hypothesized that among patients with a history of ulcer bleeding who receive prophylaxis with a PPI, celecoxib would be superior to naproxen for the prevention of recurrent ulcer bleeding irrespective of concomitant use of aspirin.
NCT00383487	A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer	Terminated	Novacea	Phase 2	2005-03-01	To determine whether, in this patient population, treatment with calcitriol and Naproxen is more effective in delaying the growth of prostate cancer than treatment with calcitriol alone as seen in historical controls.
NCT00383487	A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer	Terminated	Stanford University	Phase 2	2005-03-01	To determine whether, in this patient population, treatment with calcitriol and Naproxen is more effective in delaying the growth of prostate cancer than treatment with calcitriol alone as seen in historical controls.
NCT00527904	A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)	Completed	POZEN	Phase 3	2007-03-01	This study uses an open-label design and will be conducted in approximately 60 sites aiming to enroll a total number of 200 subjects to ensure that at least 100 subjects will have 12 months exposure to PN400 (VIMOVO).

Clinical Trial Conditions for Ec-naprosyn

Condition Name

Condition Name for Ec-naprosyn
Intervention	Trials
Healthy	4
Osteoarthritis	3
Gastric Ulcer	2
Trauma	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Ec-naprosyn
Intervention	Trials
Migraine Disorders	3
Osteoarthritis	3
Stomach Ulcer	3
Rib Fractures	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Ec-naprosyn

Trials by Country

Trials by Country for Ec-naprosyn
Location	Trials
United States	30
Sweden	4
Canada	4
United Kingdom	2
Australia	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Ec-naprosyn
Location	Trials
New York	2
Maryland	2
North Carolina	2
California	2
Texas	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Ec-naprosyn

Clinical Trial Phase

Clinical Trial Phase for Ec-naprosyn
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	2
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Ec-naprosyn
Clinical Trial Phase	Trials
Completed	11
Recruiting	6
Unknown status	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Ec-naprosyn

Sponsor Name

Sponsor Name for Ec-naprosyn
Sponsor	Trials
AstraZeneca	3
Sahlgrenska University Hospital, Sweden	2
Logical Therapeutics	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Ec-naprosyn
Sponsor	Trials
Other	17
Industry	13
NIH	1

Export unavailable in trial.
Subscribe for complete access.